Examkin

Soru

Zorluk: OrtaGynecologic Infections

An 19-year-old female college student visits the student health clinic reporting a three-day history of a persistent, unpleasant vaginal odor and a newly developed thin discharge. She recently became sexually active with a new male partner and uses oral contraceptives consistently. Her temperature is 37.1°C (98.8°F), blood pressure is 110/70 mm Hg, and pulse is 76/min. Abdominal examination reveals no tenderness or guarding. Pelvic examination demonstrates a thin, homogeneous, grayish-white discharge pooling in the posterior fornix without underlying vulvovaginal erythema. The cervix is visually unremarkable, and bimanual examination elicits no cervical motion or adnexal tenderness. The vaginal pH is measured at 5.5. Microscopic evaluation of the vaginal fluid mixed with normal saline demonstrates squamous epithelial cells with blurred, stippled borders. Which of the following is the most appropriate next step in the management of this patient?

  1. Initiate a seven-day course of oral metronidazoleCevap
  2. B
    Reassure the patient that these findings represent normal physiologic discharge
  3. C
    Administer intramuscular ceftriaxone and oral doxycycline
  4. D
    Perform a cervical biopsy to evaluate for underlying dysplasia
  5. E
    Contact her sexual partner to initiate empiric antimicrobial therapy

Cevap

Initiate a seven-day course of oral metronidazole
The correct intervention is to initiate oral metronidazole. This patient meets the Amsel criteria for bacterial vaginosis (BV), which requires at least three of the following four findings: (1) a thin, homogeneous, grayish-white vaginal discharge; (2) vaginal fluid pH > 4.5; (3) a positive 'whiff test' (release of a fishy, amine odor upon addition of potassium hydroxide); and (4) the presence of clue cells on wet mount microscopy. Clue cells are squamous epithelial cells whose borders are obscured by adhering coccobacilli. The first-line treatment for symptomatic BV in non-pregnant patients is a seven-day course of oral metronidazole or an intravaginal regimen of metronidazole or clindamycin.

Adım Adım Çözüm

1
Analyze the patient's symptoms and physical examination findings.
The patient has a malodorous, thin, grayish-white vaginal discharge with an elevated vaginal pH of 5.5 and no signs of systemic infection or upper genital tract involvement.
Establishing the specific characteristics of the discharge and ruling out upper genital tract disease (PID) narrows the differential diagnosis to forms of acute vaginitis.
2
Interpret the microscopic laboratory findings (wet mount).
The presence of squamous epithelial cells with blurred, stippled borders indicates 'clue cells'.
Clue cells are the pathognomonic microscopic finding for bacterial vaginosis, caused by Gardnerella vaginalis and other anaerobic bacteria adhering to the cell surface.
3
Determine the first-line pharmacotherapy for the diagnosed condition.
The most appropriate management for symptomatic bacterial vaginosis is a targeted antimicrobial agent, specifically metronidazole or clindamycin.
Clinical guidelines require treatment of symptomatic bacterial vaginosis to relieve symptoms and reduce the risk of acquiring other sexually transmitted infections.

Anahtar Kavram

Diagnosis of bacterial vaginosis via Amsel criteria (thin gray discharge, pH > 4.5, positive whiff test, clue cells) and first-line treatment with metronidazole.
Tahmini Süre:1m 0s
Bu soruyu puanla

Konular

Gynecologic Infections

Bu konudan daha fazla soru